NO893565L - Etansulfonamidderivater og fremgangsmaate for deres fremstilling. - Google Patents

Etansulfonamidderivater og fremgangsmaate for deres fremstilling.

Info

Publication number
NO893565L
NO893565L NO89893565A NO893565A NO893565L NO 893565 L NO893565 L NO 893565L NO 89893565 A NO89893565 A NO 89893565A NO 893565 A NO893565 A NO 893565A NO 893565 L NO893565 L NO 893565L
Authority
NO
Norway
Prior art keywords
ethansulphonamide
procedures
derivatives
preparation
ethansulphonamide derivatives
Prior art date
Application number
NO89893565A
Other languages
English (en)
Norwegian (no)
Other versions
NO893565D0 (no
Inventor
Ronald K Russell
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/240,976 external-priority patent/US4874771A/en
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO893565D0 publication Critical patent/NO893565D0/no
Publication of NO893565L publication Critical patent/NO893565L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/78—Halides of sulfonic acids
    • C07C309/79—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms
    • C07C309/83—Halides of sulfonic acids having halosulfonyl groups bound to acyclic carbon atoms of a carbon skeleton substituted by nitrogen atoms, not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO89893565A 1988-09-06 1989-09-05 Etansulfonamidderivater og fremgangsmaate for deres fremstilling. NO893565L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/240,976 US4874771A (en) 1988-09-06 1988-09-06 Ethanesulfonamide derivatives
US07/391,797 US5112866A (en) 1988-09-06 1989-08-14 Ethanesulfonamide derivatives

Publications (2)

Publication Number Publication Date
NO893565D0 NO893565D0 (no) 1989-09-05
NO893565L true NO893565L (no) 1990-03-07

Family

ID=26933874

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89893565A NO893565L (no) 1988-09-06 1989-09-05 Etansulfonamidderivater og fremgangsmaate for deres fremstilling.

Country Status (11)

Country Link
US (1) US5112866A (ja)
EP (1) EP0358438A3 (ja)
JP (1) JPH02167272A (ja)
KR (1) KR900004709A (ja)
CN (1) CN1041361A (ja)
AU (2) AU616299B2 (ja)
DK (1) DK439789A (ja)
FI (1) FI894181A (ja)
HU (1) HUT53893A (ja)
NO (1) NO893565L (ja)
PT (1) PT91634A (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227183B1 (en) * 1997-04-28 2010-09-28 Encysive Pharmaceuticals Inc Sulfonamide derivatives and pharmaceutical compositions containing them for the treatment of endothelin-mediated disorders
EP4295841A3 (en) * 2014-06-06 2024-03-13 The Scripps Research Institute Sulfur (vi) fluoride compounds and their use in click-reaction
US20190167604A1 (en) * 2014-06-06 2019-06-06 The Scripps Research Institute Arylfluorosulfate compounds and methods
CN113461577B (zh) * 2021-09-01 2021-12-14 中山大学附属第七医院(深圳) 一种氨基脂质及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1104968B (de) * 1958-01-15 1961-04-20 Hoechst Ag Verfahren zur Herstellung von ª‰-(Fluorsulfonyl)-aethyl-aminen
FR2297211A1 (fr) * 1975-01-13 1976-08-06 Eastman Kodak Co Nouveaux composes aromatiques fluorosulfones
DE3011481A1 (de) * 1979-03-30 1980-10-09 Eastman Kodak Co Benzothiazol-2-yl-monoazofarbstoffe sowie verwendung derselben zum faerben von textilen gebilden
US4265812A (en) * 1979-06-01 1981-05-05 Eastman Kodak Company Azo dyes derived from 3-amino-2,1-benzisothiazoles and aromatic amine couplers containing sulfo groups, or salts thereof
US4293557A (en) * 1979-07-03 1981-10-06 Teikoku Hormone Mfg. Co., Ltd. Antiulcer phenoxypropylamine derivatives
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
SE458606B (sv) * 1987-04-10 1989-04-17 Huhtamaeki Oy 2-ftalimidoetansulfon-n-arylamider och foerfarande foer framstaellning av dessa

Also Published As

Publication number Publication date
CN1041361A (zh) 1990-04-18
DK439789D0 (da) 1989-09-05
FI894181A0 (fi) 1989-09-05
KR900004709A (ko) 1990-04-12
JPH02167272A (ja) 1990-06-27
PT91634A (pt) 1990-03-30
US5112866A (en) 1992-05-12
EP0358438A3 (en) 1991-10-09
HUT53893A (en) 1990-12-28
FI894181A (fi) 1990-03-07
AU8156991A (en) 1991-10-31
DK439789A (da) 1990-03-07
EP0358438A2 (en) 1990-03-14
NO893565D0 (no) 1989-09-05
AU4104389A (en) 1990-03-15
AU616299B2 (en) 1991-10-24

Similar Documents

Publication Publication Date Title
NO893678L (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
DK609489A (da) Imidazolderivater, deres fremstilling og anvendelse
NO892745D0 (no) Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling.
NO891866L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO892808D0 (no) (aza)naftalensultam-derivater og deres fremstilling.
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
DK595388A (da) Benzopyranderivater, deres fremstilling og anvendelse
NO895030L (no) 2-imino-benzotiazolinderivater og deres fremstilling.
NO892494L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
DK193088A (da) 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse
DK530689D0 (da) Adenylcyclasederivater, fremgangsmaade til fremstilling deraf og deres anvendelse
NO894103L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
DK278188A (da) Thiazolidin-4-on-derivater, deres fremstilling og anvendelse
NO883114L (no) 1h-pyrazol-1-alkanamider og fremgangsmaate for deres fremstilling.
DK469389A (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
DK189488A (da) Imidazothiadiazinderivater, deres fremstilling og anvendelse
NO893653D0 (no) Quinolinderivater og deres fremstilling.
NO893565D0 (no) Etansulfonamidderivater og fremgangsmaate for deres fremstilling.
NO894697D0 (no) Penemderivater og fremgangsmaater for deres fremstilling.
DK223288A (da) Benzensulfornamid-derivater, deres fremstilling og anvendelse
DK412188D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
NO873126D0 (no) Cefalosporiner og derivater derav og fremgangsmaater for deres fremstilling.
DK361388A (da) Cephemderivater, deres fremstilling og anvendelse
DK613888A (da) Acyllabdan-derivater, deres fremstilling og anvendelse
DK668788D0 (da) Labdanderivater, deres fremstilling og anvendelse